CALIFORNIA NANOTECHNOLOGIES APPOINTS DR. ENRIQUE LAVERNIA TO THE BOARD
Created at :
Aug 6, 2014
TSX VENTURE: CNO
CERRITOS, CA, August 6, 2014 – California Nanotechnologies Corp. (“Cal Nano” or the “Company”) is pleased to announce the appointment of Dr. Enrique Lavernia, Distinguished Professor and Dean of the College of Engineering at the University of California at Davis, to the Board of Directors of California Nanotechnologies Corp. Dr. Lavernia will replace David F. Grant on the Board. Mr. Grant will continue to support the development of the Company as a consultant.
Since the completion of his PhD in Materials Engineering at the Massachusetts Institute of Technology (MIT) in 1986, Dean Lavernia has served in various positions including as Chair and Chancellor's Professor of the Department of Chemical Engineering and Materials Science at the University of California at Irvine and as Provost and Executive Vice Chancellor of the University of California at Davis. He is a member of several professional organizations and fellowships and serves on various boards of review and advisory panels. In addition to his nine patents, Dean Lavernia has received numerous scholastic awards. He has also been awarded grants from several agencies including the National Science Foundation, the Office of Naval Research, the U.S. Department of Energy, NASA, and the Air Force Office of Scientific Research.
Dean Lavernia will receive 100,000 incentive stock options at a price of $0.11 CAD per share as compensation for joining the Board. The options are governed by the Company's stock option plan as approved at the last annual meeting on October 18, 2013 and as such vest over three years and are exercisable over a term of five years. All options offered by the Company are subject to TSX Venture Exchange (TSX-V) approval.
Dean Lavernia brings to Cal Nano a vast network of contacts and unparalleled expertise in the field of material science. To further support the commercialization of the Company, Dean Lavernia will provide consulting services to develop new and advance existing commercial projects. “The addition of Dean Lavernia to the Cal Nano team will provide additional insight and expertise into the commercial world of Nanotechnology. We look forward to many additional opportunities and commercial successes to come,” stated Christopher Melnyk, CEO.
The Company plans to put forward a larger slate of directors at the annual meeting to be held in Calgary this fall. At that time, it will be possible for Mr. David Grant to return to the Board.
For further information, please contact:
Doren Quinton, President QIS Capital
T: (250) 377-1182
Andrew Bengis, Chief Financial Officer
T: (562) 991-5211
F: (562) 926-6913